Global Neurodegeneration Proteomics Consortium

By uniting diverse data and researchers working on neurodegenerative disorders globally, we seek to contribute to the advancement of the diagnosis and treatment of conditions impacting over 57 million people in need. To date, the GNPC has gathered over 40,000 patient samples from over 20 international research groups to create our V1 Harmonized Data Set (HDS), comprising nearly 300,000,000 unique protein measurements. The HDS spans multiple neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).